RecruitingNot ApplicableNCT06740318

Recompensation in Alcohol Related Hepatitis

Recompensation in Alcohol Related Hepatitis- A Prospective Cohort With Alcohol Cessation


Sponsor

Nina Kimer

Enrollment

160 participants

Start Date

Nov 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Genetic activity and metabolic changes may be part of the pathogenesis in alcohol related hepatitis. We do not know exactly how alcohol cessation affects liver functions and metabolism. The aim of this study is to assess the impact of alcohol cessation in patients with alcohol related hepatitis and gain knowledge of the metabolic and genetic functions of the liver during remission and recompensation from alcohol related hepatitis. The study will assess 1. The effect of alcohol cessation on the liver. 2. The biological mechanisms involved in healing after alvohol-cessation 3. The effect of motivational enhcament therapy in alcohol cessation after alcohol related hepatitis. 4. The metabolic changes of lipids and proteins in the liver Participants are offered motivational enhancement therapy and standard of care.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Clinical suspicion of AH, supported by biochemistry (bilirubin 50 mmol/l or higher) and ultrasound or other imaging techniques.
  • Informed written consent.

Exclusion Criteria4

  • People where the diagnosis of AH is questioned with reasonable doubt.
  • Withdrawal of informed consent.
  • Persons eligible for inclusion where the investigational program is delayed or not initiated within two months after the diagnosis of suspected AH.
  • Persons with hepatocellular carcinoma

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMotivational enhancement therapy

The intervention consists of three motivational interviews with the focus to enhance the participants motivation to enter treatment of alcohol use disorder. the interviews are structured and based on the model Motivational enhancement therapy.


Locations(1)

University Hospital Hvidovre

Hvidovre, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06740318